Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedOct 01, 2025
DataAggregated Company Financials
Companies15
  • 7D0.9%
  • 3M5.8%
  • 1Y-4.9%
  • YTD4.7%

The Pharma is pretty flat in the last 7 days, but GSK has stood out, gaining 5.4%. Unfortunately though, the industry is down 4.9% over the past 12 months. As for the next few years, earnings are expected to grow by 14% per annum.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 01 Oct 2025UK£271.4bUK£87.7bUK£11.7b19x23.2x3.1x
Fri, 29 Aug 2025UK£280.4bUK£87.5bUK£11.7b21.2x24x3.2x
Sun, 27 Jul 2025UK£263.5bUK£86.6bUK£10.7b29.8x24.7x3x
Tue, 24 Jun 2025UK£259.6bUK£86.4bUK£10.6b26x24.5x3x
Thu, 22 May 2025UK£264.7bUK£86.7bUK£10.7b27x24.8x3.1x
Sat, 19 Apr 2025UK£252.1bUK£86.5bUK£9.6b26.7x26.3x2.9x
Mon, 17 Mar 2025UK£290.1bUK£87.7bUK£9.6b28.8x30.2x3.3x
Wed, 12 Feb 2025UK£282.5bUK£89.5bUK£9.5b30.5x29.6x3.2x
Fri, 10 Jan 2025UK£233.1bUK£76.3bUK£7.9b32.1x29.5x3.1x
Sun, 08 Dec 2024UK£227.6bUK£74.8bUK£7.7b32.1x29.5x3x
Tue, 05 Nov 2024UK£236.4bUK£72.5bUK£7.6b31.1x31.3x3.3x
Thu, 03 Oct 2024UK£252.6bUK£71.6bUK£9.0b30.4x28.2x3.5x
Sat, 31 Aug 2024UK£280.9bUK£72.0bUK£9.0b42x31.3x3.9x
Mon, 29 Jul 2024UK£259.8bUK£72.2bUK£9.6b34.8x27.2x3.6x
Wed, 26 Jun 2024UK£267.3bUK£71.6bUK£9.6b30.2x28x3.7x
Fri, 24 May 2024UK£272.7bUK£71.6bUK£9.6b32.7x28.5x3.8x
Sun, 21 Apr 2024UK£244.3bUK£71.6bUK£9.8b31.8x24.9x3.4x
Tue, 19 Mar 2024UK£236.4bUK£70.4bUK£9.7b31.9x24.3x3.4x
Thu, 15 Feb 2024UK£225.5bUK£69.9bUK£9.6b34.6x23.4x3.2x
Sat, 13 Jan 2024UK£244.2bUK£68.8bUK£10.7b37.2x22.9x3.5x
Mon, 11 Dec 2023UK£226.9bUK£69.4bUK£10.7b33.4x21.1x3.3x
Wed, 08 Nov 2023UK£230.2bUK£70.6bUK£11.0b52.9x20.9x3.3x
Fri, 06 Oct 2023UK£243.3bUK£70.7bUK£10.4b74.9x23.3x3.4x
Sun, 03 Sep 2023UK£236.9bUK£69.4bUK£10.2b53.5x23.2x3.4x
Tue, 01 Aug 2023UK£243.7bUK£68.4bUK£10.1b52.3x24x3.6x
Thu, 29 Jun 2023UK£243.4bUK£68.0bUK£7.9b55.5x30.8x3.6x
Sat, 27 May 2023UK£251.7bUK£68.9bUK£8.0b55.5x31.5x3.7x
Mon, 24 Apr 2023UK£262.0bUK£69.2bUK£6.9b63.2x38.2x3.8x
Wed, 22 Mar 2023UK£238.3bUK£69.9bUK£6.9b54.3x34.5x3.4x
Fri, 17 Feb 2023UK£248.1bUK£70.5bUK£7.4b41.2x33.6x3.5x
Sun, 15 Jan 2023UK£252.3bUK£79.6bUK£6.3b39x40x3.2x
Tue, 13 Dec 2022UK£246.5bUK£79.5bUK£6.3b37.3x39.1x3.1x
Thu, 10 Nov 2022UK£240.9bUK£80.6bUK£3.6b21.1x67.2x3x
Sat, 08 Oct 2022UK£220.0bUK£81.3bUK£3.6b19.5x60.3x2.7x
Price to Earnings Ratio

60.3x


Total Market Cap: UK£220.0bTotal Earnings: UK£3.6bTotal Revenue: UK£81.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 30.8x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 23.2x which is lower than its 3-year average PE of 30.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 48% per year over the last three years.
  • Revenues for these companies have grown 2.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.54%
Healthcare0.72%
Pharma0.88%
Pharma0.88%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GSK GSKUK£15.755.4%
+UK£3.2b
3.5%PE18.5x
HIK Hikma PharmaceuticalsUK£16.984.5%
+UK£161.7m
-11.1%PE13.6x
HLN HaleonUK£3.320.5%
+UK£116.1m
-15.8%PE19.5x
AGY Allergy TherapeuticsUK£0.0851.8%
+UK£7.1m
83.7%PS7.2x
EAH ECO Animal Health GroupUK£0.965.5%
+UK£3.4m
26.3%PE38.6x

Latest News